Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01166763 · ClinicalTrials.gov registry record · NA
Modulation of Breast Cancer Risk Biomarkers by High Dose Vitamin D
A NA study, sponsored by Carol Fabian, MD.
- Completed
- Registry status
- NA
- Development phase
- 30
- Enrollment target
NCT01166763: Completed NA study, sponsored by Carol Fabian, MD.
NCT01166763 is a NA study that has completed, run by Carol Fabian, MD. The registered enrollment target is 30 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01166763, a NA study, has completed, sponsored by Carol Fabian, MD.
- COMPLETED
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
Study Summary
The overall goal of this project is to determine if high dose vitamin D3 given to premenopausal women at high risk for development of breast cancer, who initially have insufficient levels of 25-hydroxy vitamin D (\<30 ng/ml), will raise 25(OH)D levels above 50 ng/ml. If so, will certain risk biomarkers for development of breast cancer be reliably and favorably modulated?
Primary Outcome
Change in the percent of the breast area that is considered to be at higher density on mammogram.
Interventions
- DRUG vitamin D3
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2009-05 |
| Est. Completion | 2011-06 |
| Phase | NA |
What the finished NCT01166763 record still lists
NCT01166763 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 1 intervention - of which vitamin D3 is the first listed.
NCT01166763 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01166763 about?
NCT01166763 is a clinical study titled "Modulation of Breast Cancer Risk Biomarkers by High Dose Vitamin D". The overall goal of this project is to determine if high dose vitamin D3 given to premenopausal women at high risk for development of breast cancer, who initially have insufficient levels of 25-hydroxy vitamin D (\<30 ng/ml), will raise 25(OH)D levels above 50 ng/ml. If so, will certain risk biomark...
What is the current status of trial NCT01166763?
This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2009-05. Estimated completion is 2011-06.
What interventions are being tested in trial NCT01166763?
The interventions under investigation include: vitamin D3 (DRUG).
Who is sponsoring clinical trial NCT01166763?
This trial is sponsored by Carol Fabian, MD, which has 14 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01166763's enrollment target sits among peer trials
30 1593rd of 2000 higher than 299 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia